Trace-level determination of potential genotoxic impurities in quetiapine fumarate using LC-MS
- PMID: 36541925
- DOI: 10.1002/bmc.5575
Trace-level determination of potential genotoxic impurities in quetiapine fumarate using LC-MS
Abstract
A novel LC-MS method was developed and validated to determine three potential genotoxic impurities, namely 2-(2-aminophenylthio)benzoic acid hydrochloride, 2-aminothiophenol, and 2-(2-aminophenylthio)benzonitrile, at trace level (~1.6 ppm) in quetiapine fumarate drug substance, an antipsychotic drug. These impurities are potentially genotoxic and therefore should be controlled at or below specific acceptance limits. An InertSustain AQ-C18 column (250 × 4.6 mm, 5 μm) in reversed-phase mode with the column temperature at 45°C was used. The mobile phase was 0.1% trifluoroacetic acid in water and acetonitrile with gradient elution mode, and the run time was 45 min. The flow rate was 0.8 ml/min. A mass spectrometer was used to quantify the amount of impurities using electrospray ionization mode at specific m/z 245.9, 126.0, and 226.9 for 2-(2-aminophenylthio)benzoic acid hydrochloride, 2-aminothiophenol, and 2-(2-aminophenylthio) benzonitrile, respectively. The method was found to be sensitive and possessed excellent linearity in the concentration ranges from the limit of quantification to 150% of the permitted level (0.47-2.36 μg/ml) with correlation coefficients above 0.999. The results showed that the method was specific, precise, linear, and accurate for the estimation of these three impurities in quetiapine fumarate.
Keywords: 2-(2-aminophenylthio)benzoicacid hydrochloride; 2-(2-aminophenylthio)benzonitrile; 2-aminothiophenol; LC-MS; genotoxic impurities; quetiapine fumarate.
© 2022 John Wiley & Sons Ltd.
References
REFERENCES
-
- Dedania, Z. R., Sheth, N. R., & Dedania, R. R. (2013). Stability indicating high-performance thin-layer chromatographic determination of quetiapine fumarate. International Journal of Pharmaceutical Sciences and Research, 4(6), 2406-2414. https://doi.org/10.13040/IJPSR.0975-8232.4(6).2406-14
-
- Dhaneshwar, S. R., Patre, N. G., & Mahadik, M. V. (2009). Stability-indicating HPTLC method for quantitation of quetiapine fumarate in the pharmaceutical dosage form. Acta Chromatographica, 21(1), 83-93. https://doi.org/10.1556/achrom.21.2009.1.7
-
- Kumar, N., Sangeetha, D., Goyal, R., & Reddy, P. S. (2013). A validated stability-indicating RP-LC method for the estimation of process-related impurities and degradation products of quetiapine fumarate in solid oral dosage form. Acta Chromatographica, 25(2), 393-409. https://doi.org/10.1556/AChrom.25.2013.2.13
-
- Kwak, B. S., Sang-II, L., Hee-Jun, H., & Jong-Ho, L. (2010). Process for the preparation of 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl)dibenzo[B,F][1,4]thiazepine. 2010 Patent No. US 7678902B2.
-
- Marta de, D., Cristobal, C., Diana, C., Sigrid, M., Ricardo, G., & Carola, V. (2019). Degradation studies of quetiapine fumarate by liquid chromatography-diode array detection and tandem mass spectrometry methods. Biomedical Chromatography, 33(11), e4655. https://doi.org/10.1002/bmc.4655
MeSH terms
Substances
LinkOut - more resources
Full Text Sources